HFpEF is strongly associated with obesity and metabolic dysfunction, and this is the first demonstration that treating the underlying obesity significantly improves HFpEF outcomespotentially establishing a new treatment paradigm
Gut (2017) 66:18090
Elsner U, Henrichs M, Gosheger G, Dieckmann R, Nottrott M, Hardes J, et al
Clinical research supports this pattern
Weekly subcutaneous injections of tirzepatide show promise in treating both type 2 diabetes and cardiometabolic disorders
Peaka GLP-1, sometimes searched as "Peak GLP-1," is an over-the-counter dietary supplement sold as "ultra concentrated essence liquid pearls." The product claims to support weight loss, reduce appetite, improve metabolic function, and even help with blood sugar regulation